Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 325 of 1294 entries
View as:

Investigation on Safety, Tolerability and Pharmacokinetics of Multiple Doses of NNC0113-0987 in an Oral Formulation in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01978613 Org: User:
Start: 11/30/13 End: 06/30/14 Due: 06/30/15

Comparison of Two Biphasic Insulin Aspart 30 Formulations (Current and New Formulation) in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01487811 Org: User:
Start: 05/31/05 End: 11/30/05 Due: 11/30/06

A Trial Investigating the Efficacy and Safety of Insulin Detemir Versus Insulin NPH in Combination With Metformin and Diet/Exercise in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on Metformin With or Without Other Oral Antidiabetic Drug(s) With or Without Basal Insulin

Phase: N/A Priority: Normal
NCT ID: NCT02131272 Org: User:
Start: 06/11/14 End: 06/14/16 Due: 06/14/17

Evaluation of Recombinant Factor XIII for Prevention of Bleeding in Patients With FXIII Inherited Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT00713648 Org: User:
Start: 08/31/08 End: 04/30/10 Due: 04/30/11

The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01618162 Org: User:
Start: 08/29/12 End: 10/23/13 Due: 10/23/14

Attitudes and Unmet Needs Among Type 2 Diabetes Patients

Phase: N/A Priority: Normal
NCT ID: NCT05737810 Org: User:
Start: 03/27/23 End: 04/17/23 Due: 04/17/24

French Registry of Children Treated With Norditropin® for Short Stature Associated With Noonan Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT05308927 Org: User:
Start: 03/16/22 End: 03/17/28 Due: 03/17/29

A Trial Investigating the Safety, Tolerability, Availability and Distribution in the Body of Once-weekly Long-acting Growth Hormone (Somapacitan) Compared to Once Daily Norditropin NordiFlex® in Adults With Growth Hormone Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT01706783 Org: User:
Start: 10/12/12 End: 11/18/13 Due: 11/18/14

Comparing Semaglutide Administered Subcutaneously Once Daily to Semaglutide Administered Subcutaneously Once Weekly

Phase: N/A Priority: Normal
NCT ID: NCT02557620 Org: User:
Start: 09/30/15 End: 04/30/16 Due: 04/30/17

Safety and Efficacy of Insulin Detemir in Combination With OAD in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00604396 Org: User:
Start: 03/31/03 End: 01/31/04 Due: 01/31/05

Observational Study to Evaluate the Safety of NovoMix® 30 FlexPen®

Phase: N/A Priority: Normal
NCT ID: NCT00709683 Org: User:
Start: 05/31/08 End: 05/31/09 Due: 05/31/10

A Research Study to Look at Similarity Between Semaglutide Versions in Different Injection Tools

Phase: N/A Priority: Normal
NCT ID: NCT03598621 Org: User:
Start: 07/23/18 End: 01/17/19 Due: 01/17/20

Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00617565 Org: User:
Start: 07/08/03 End: 11/26/03 Due: 11/26/04

Bioequivalence of Two NovoLog® Formulations in Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01464099 Org: User:
Start: 06/30/08 End: 11/30/08 Due: 11/30/09

Vaginal Estradiol Tablets (Vagifem®) and Endometrial Cancer Risk in the Treatment of Postmenopausal Vaginal Atrophy

Phase: N/A Priority: Normal
NCT ID: NCT05243823 Org: User:
Start: 01/15/22 End: 07/31/22 Due: 07/31/23

A Research Study Investigating NNC0247-0829 for Weight Management in People With Overweight or Obesity

Phase: N/A Priority: Normal
NCT ID: NCT04010786 Org: User:
Start: 07/11/19 End: 06/21/22 Due: 06/21/23

A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Bangladesh

Phase: N/A Priority: Normal
NCT ID: NCT00839878 Org: User:
Start: 03/31/09 End: 03/31/09 Due: 03/31/10

Effect of Detemir and Sitagliptin on Blood Glucose Control in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00789191 Org: User:
Start: 11/30/08 End: 08/31/09 Due: 08/31/10

Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02670915 Org: User:
Start: 05/04/16 End: 03/03/18 Due: 03/03/19

Investigation on Safety, Tolerability, and Pharmacokinetics of Single Doses of NNC0113-0987 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01690169 Org: User:
Start: 09/14/12 End: 12/11/12 Due: 12/11/13

Frequency of Hypoglycaemic Episodes During Treatment With Insulin Detemir in Well Controlled Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01697657 Org: User:
Start: 09/30/01 End: 11/30/02 Due: 11/30/03

Physiological Concept of Insulin Therapy in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01536639 Org: User:
Start: 01/31/06 End: 12/31/06 Due: 12/31/07

Comparison of Human Insulin to Insulin Inhalation Solution in Children With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00567775 Org: User:
Start: 10/21/02 End: 11/20/02 Due: 11/20/03

A Trial Evaluating the Effect of NN1250 at Steady State Conditions in Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01114542 Org: User:
Start: 05/03/10 End: 08/10/10 Due: 08/10/11

Within-subject Variability of Insulin Detemir in Children and Adolescents With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01497574 Org: User:
Start: 05/31/05 End: 10/31/05 Due: 10/31/06